BUSPIRONE HYDROCHLORIDE tablet

Страна: США

мова: англійська

Джерело: NLM (National Library of Medicine)

Активний інгредієнт:

BUSPIRONE HYDROCHLORIDE (UNII: 207LT9J9OC) (BUSPIRONE - UNII:TK65WKS8HL)

Доступна з:

Contract Pharmacy Services-PA

ІПН (Міжнародна Ім'я):

BUSPIRONE HYDROCHLORIDE

Склад:

BUSPIRONE HYDROCHLORIDE 10 mg

Адміністрація маршрут:

ORAL

Тип рецепту:

PRESCRIPTION DRUG

Терапевтичні свідчення:

Buspirone hydrochloride tablets are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. The efficacy of buspirone hydrochloride tablets have been demonstrated in controlled clinical trials of outpatients whose diagnosis roughly corresponds to Generalized Anxiety Disorder (GAD). Many of the patients enrolled in these studies also had coexisting depressive symptoms and buspirone hydrochloride tablets relieved anxiety in the presence of these coexisting depressive symptoms. The patients evaluated in these studies had experienced symptoms for periods of 1 month to over 1 year prior to the study, with an average symptom duration of 6 months. Generalized Anxiety Disorder (300.02) is described in the American Psychiatric Association’s Diagnostic and Statistical Manual, III 1 as follows: Generalized, persistent anxiety (of at least 1 mont

Огляд продуктів:

Buspirone Hydrochloride Tablets, USP are available containing 10 mg of buspirone hydrochloride, USP. The 10 mg tablets are white, oval, scored tablets debossed with M to the left of the score and B2 to the right of the score on one side of the tablet and blank on the other side. They are available as follows: NDC 67046-149-07 blisterpacks of 7 tablets NDC 67046-149-14 blisterpacks of 14 tablets NDC 67046-149-15 blisterpacks of 15 tablets NDC 67046-149-21 blisterpacks of 21 tablets NDC 67046-149-28 blisterpacks of 28 tablets NDC 67046-149-30 blisterpacks of 30 tablets Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. PHARMACIST: Patient Instruction Sheet attached to prescribing information. Additional copies are provided separately.

Статус Авторизація:

Abbreviated New Drug Application

Характеристики продукта

BUSPIRONE HYDROCHLORIDE- BUSPIRONE HYDROCHLORIDE TABLET
CONTRACT PHARMACY SERVICES-PA
----------
BUSPIRONE 10 MG 149
(PATIENT INSTRUCTION SHEET INCLUDED.)
DESCRIPTION
Buspirone hydrochloride tablets, USP are an antianxiety agent that are
not chemically or
pharmacologically related to the benzodiazepines, barbiturates, or
other sedative/anxiolytic drugs.
Buspirone hydrochloride, USP is a white crystalline, water soluble
compound with a molecular weight
of 422.0. Chemically, buspirone hydrochloride is
8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-
azaspiro[4.5]decane-7,9-dione monohydrochloride. The molecular formula
C
H
N
O
•HCl is
represented by the following structural formula:
Buspirone hydrochloride tablets are supplied as tablets for oral
administration containing 5 mg, 7.5 mg,
10 mg, 15 mg or 30 mg of buspirone hydrochloride, USP (equivalent to
4.6 mg, 6.9 mg, 9.1 mg, 13.7
mg, and 27.4 mg of buspirone free base, respectively). The 5 mg and 10
mg tablets are scored so they
can be bisected. Thus, the 5 mg tablet can also provide a 2.5 mg dose,
and the 10 mg tablet can provide a
5 mg dose. The 15 mg and 30 mg tablets are provided in a multi-scored
tablet design. These tablets are
scored so they can be either bisected or trisected. Thus, a single 15
mg tablet can provide the following
doses: 15 mg (entire tablet), 10 mg (two thirds of a tablet), 7.5 mg
(one half of a tablet), or 5 mg (one
third of a tablet). A single 30 mg tablet can provide the following
doses: 30 mg (entire tablet), 20 mg
(two thirds of a tablet), 15 mg (one half of a tablet), or 10 mg (one
third of a tablet). Buspirone
hydrochloride tablets contain the following inactive ingredients:
anhydrous lactose, colloidal silicon
dioxide, magnesium stearate, microcrystalline cellulose, sodium lauryl
sulfate, and sodium starch
glycolate (potato).
CLINICAL PHARMACOLOGY
The mechanism of action of buspirone is unknown. Buspirone differs
from typical benzodiazepine
anxiolytics in that it does not exert anticonvulsant or muscle
relaxant effects. It also l